NPC1 and nasopharyngeal carcinoma: In an exploratory study on the treatment of NPC, HP-β-CyD, which was initially used as a solubilizer for a candidate compound (allopregnanolone), was found to improve disease symptoms in Npc1-deficient mice [17,172].